Modular Study to Evaluate CT7001 Alone in Cancer Patients With Advanced Malignancies
Completed · Phase 1/Phase 2
Conditions studied: Advanced Solid Malignancies
In brief
This is a modular, Phase I/II, multicentre study to investigate CT7001 monotherapy in advanced solid malignancies and to further investigate CT7001 as monotherapy or in combination with standard therapy in specific participant groups with Triple Negative Breast Cancer (TNBC), Castrate Resistant Prostate Cancer (CRPC) and in combination with fulvestrant for patients with hormone receptor-positive (HR+ve) / human epidermal growth factor-2 negative (HER2-ve) breast cancer.
Key facts
- Study ID
- NCT03363893
- Run by
- Carrick Therapeutics Limited
- People needed
- 124
- Starts
- 2017-11-14
- Expected to finish
- 2022-12-15
- Last updated by the study team
- 2026-06-23
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Research Site 54 — Tucson, Arizona, United States
- Research Site 31 — Beverly Hills, California, United States
- Research Site 37 — Tampa, Florida, United States
- Research Site 38 — Chicago, Illinois, United States
- Research Site 34 — Boston, Massachusetts, United States
- Research Site 47 — Cincinnati, Ohio, United States
- Research Site 39 — Columbus, Ohio, United States
- Research Site 36 — Portland, Oregon, United States
- Research Site 44 — Austin, Texas, United States
- Research Site 46 — Dallas, Texas, United States
- Research Site 48 — Salt Lake City, Utah, United States
- Research Site 33 — Salem, Virginia, United States
- Research site 11 — Brighton, United Kingdom
- Research site 5 — Cambridge, United Kingdom
- Research Site 7 — Glasgow, United Kingdom
- Research Site 10 — Liverpool, United Kingdom
- Research Site 9 — London, United Kingdom
- Research Site 8 — London, United Kingdom
- Research Site 3 — London, United Kingdom
- Research Site 1 — Manchester, United Kingdom
- Research Site 4 — Manchester, United Kingdom
- Research Site 2 — Oxford, United Kingdom
- Research Site 6 — Southampton, United Kingdom
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.